Expanded Access 2.0

January 22-23, 2019

National Press Club – Washington D.C.

Produced By

The Second Annual National Forum on Pre-Approval Access

Integrating treatment-use trials into the clinical development of new therapeutics for serious diseases

  • The Biggest Event in Expanded Access
    After last year’s success, we are targeting 300+ attendees for Round 2.  Our new venue has capacity to comfortably seat the leaders from industry, medical academia, policy institutes, and non-profit organizations.
  • A Special Summit Format
    Get past the basics quickly and chart new ground into pivotal issues such as reimbursement, investigator engagement, secondary data assets, and integration with clinical research.  Our panel format works!
  • The Best Venue
    Experience our premier conference at the historic National Press Club, with discounted rooms at the JW Marriott, located only one block away.
  • The Most Credible Material
    The Summit is produced and organized by subject matter experts, not by a conference company.  We launched the Summit in 2017 to establish a definitive national forum for advancing our space.  Let’s build on that success!
  • The Strongest Speakers
    We know the top speakers in Expanded Access, and we carefully select them from a deep pool of industry experts plus delegates from FDA, NIH, and CMS. Many good speakers don’t make our list.
  • The Highest Production Quality
    Breakthroughs happen when attendees and speakers are happy! So you’ll be taken care of with gourmet food, comfortable seating, deluxe audio/video, and lots of extras!

The top conference on pre-approval treatment access, by design!

Featured Speakers

Conference Location

National Press Club

The Expanded Access Summit will be held at the National Press Club Main Ballroom in the historic National Press Building.

Conference attendees can secure a special rate at the JW Marriott, which is located next to the National Press Building.

Take advantage of our negotiated room rate of $269/night for a King room.
Online reservations are now open.

You can book online using this link.

If you prefer to book over the phone, please call (800) 393-2503

Highlights from the
2017 Expanded Access Summit

Join Attendees from world-class
companies and organizations

2017 companies included Pfizer, Takeda, Janssen, Bayer, Eli Lilly, Biogen, Alnylam, Vertex, Bluebird, Amicus, Ultragenyx, AmpliPhi, Wave Life Sciences, Neuralstem, Incyte, Asuragen, Astellas, Tesaro, Ovid, Spectrum, ALS Association, Parent Project Muscular Dystrophy, Kids V Cancer, BIO, FDA, NIH, Patient Advocate Foundation, the FNIH Biomakers Consortium, and more.

What People Say about the Summit

Great speakers / topics and overall very well done.

Nancy Beck
Avalere Health

The Expanded Access Summit provided attendees a front row seat for a lively exchange of opinions by distinguished KOLs addressing the ethical and logistical challenges in providing marginalized patients with earlier access to experimental therapies.

Maria Hardin
Patient Assistance Fund Consultant

The Expanded Access Summit provided a platform where attendees could not only get up to speed on changes regarding Expanded Access but could also have an open dialogue. And the food was superb!

Jennifer Cahill
North Highland



We look forward to seeing you in WASHINGTON!

Register now to ensure best price admission and hotel room availability.